Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Yan

Showing results (361-370 of 387) with videos related to

Pageof 39
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|February 22, 2023
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerCharles Shing Kam, Daniel Wai-Hung Ho, Vanessa Sheung-In Ming, et al.
Journal of Global Health|December 29, 2022
Mapping national information and communication technology (ICT) infrastructure to the requirements of potential digital health interventions in low- and middle-income countriesChi Yan Hui, Adina Abdulla, Zakiuddin Ahmed, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 16, 2024
Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC CellsYu-Man Tsui, Daniel Wai-Hung Ho, Karen Man-Fong Sze, et al.
Blood Advances|March 8, 2024
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myelomaCoty Hing Yau Cheung, Chi Keung Cheng, Kam Tong Leung, et al.
Hepatology (Baltimore, Md.)|March 15, 2020
Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular CarcinomaKaren Man-Fong Sze, Daniel Wai-Hung Ho, Yung-Tuen Chiu, et al.
Annals of Palliative Medicine|October 21, 2022
Supportive care and symptom management in patients with advanced hematological malignancies: a literature reviewKwok Ying Chan, Thomas Sau Yan Chan, Harinder Gill, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Dual-tracer PET/CT in the management of hepatocellular carcinomaKeith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, et al.
Theranostics|January 3, 2024
Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinomaQingyang Zhang, Yu-Man Tsui, Vanilla Xin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK InhibitionRebecca L Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray, et al.
Liver Cancer|May 17, 2024
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular CarcinomaChi Leung Chiang, Francis Ann Shing Lee, Kenneth Sik Kwan Chan, et al.
Pageof 39

Showing results (361-370 of 387) with videos related to

Sort By:
Pageof 39
Cellular and Molecular Gastroenterology and Hepatology|February 22, 2023
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerCharles Shing Kam, Daniel Wai-Hung Ho, Vanessa Sheung-In Ming, et al.
Journal of Global Health|December 29, 2022
Mapping national information and communication technology (ICT) infrastructure to the requirements of potential digital health interventions in low- and middle-income countriesChi Yan Hui, Adina Abdulla, Zakiuddin Ahmed, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 16, 2024
Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC CellsYu-Man Tsui, Daniel Wai-Hung Ho, Karen Man-Fong Sze, et al.
Blood Advances|March 8, 2024
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myelomaCoty Hing Yau Cheung, Chi Keung Cheng, Kam Tong Leung, et al.
Hepatology (Baltimore, Md.)|March 15, 2020
Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular CarcinomaKaren Man-Fong Sze, Daniel Wai-Hung Ho, Yung-Tuen Chiu, et al.
Annals of Palliative Medicine|October 21, 2022
Supportive care and symptom management in patients with advanced hematological malignancies: a literature reviewKwok Ying Chan, Thomas Sau Yan Chan, Harinder Gill, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Dual-tracer PET/CT in the management of hepatocellular carcinomaKeith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, et al.
Theranostics|January 3, 2024
Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinomaQingyang Zhang, Yu-Man Tsui, Vanilla Xin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK InhibitionRebecca L Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray, et al.
Liver Cancer|May 17, 2024
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular CarcinomaChi Leung Chiang, Francis Ann Shing Lee, Kenneth Sik Kwan Chan, et al.
Pageof 39